Open access
Oct 2026
Prognostic Factors for Progression-Free Survival in Patients with Advanced Gastric Cancer Treated with First-Line Nivolumab Plus Oxaliplatin-Based Chemotherapy: Combined Clinical and Baseline CT Features
Background: Although nivolumab plus platinum-based chemotherapy has been approved as a first-line systemic treatment for advanced gastric cancer (AGC), the pretreatment imaging and clinical factors associated with disease progression remain incompletely understood. Methods: This retrospective study included 172 patient...
H. Rhee, Joon Seok Lim, Jin-Young Choi et al.
· Tomography · 0 citations